Laboratoire ChemTox, Illkirch, France.
Forensic Sci Int. 2010 Mar 20;196(1-3):51-4. doi: 10.1016/j.forsciint.2009.12.033. Epub 2010 Jan 8.
Methadone is not licensed for use in children though it can be employed for the management of neonatal opiate withdrawal syndrome. During the last 2 years, our laboratory has been asked to test for methadone and EDDP, its major metabolite, in hair from children that were admitted to hospital unconscious and where methadone had already been identified in a body fluid (4 cases) or where the children were deceased and evidence of methadone overdosage having already been established (2 cases). In all of these cases, segmental analysis revealed approximately the same amount of drug along the hair lock. As a consequence, contamination was considered as an issue and interpretation of the results was a challenge that deserves particular attention. After decontamination with dichloromethane and segmentation the hair was cut into small pieces, incubated overnight at 40 degrees C, liquid-liquid extracted and analysed with LC-MS/MS, using 2 transitions per compound. The LOQ for both methadone and EDDP was 10 pg/mg. In the first series involving children admitted to hospital, the following results were obtained: * case 1: 4 x 1 cm section, methadone at 0.05-0.08 ng/mg, no EDDP detected, * case 2: 4 x 1 cm section, methadone at 0.13-0.15 ng/mg, EDDP at 0.02 ng/mg, * case 3: 3 x 1.5 cm section, methadone at 0.07-0.09 ng/mg, EDDP at 0.01-0.03 ng/mg, * case 4: 6 x 2 cm section, methadone at 0.06-0.13 ng/mg, EDDP at 0.02-0.03 ng/mg. The following concentrations were obtained from the children who had died following a methadone overdose: * case 5: 2 x 2 cm section, methadone at 0.53-0.58 ng/mg, no EDDP detected, * case 6: 4 x 1 cm section, methadone at 0.44-0.77 ng/mg, EDDP at 0.04-0.06 ng/mg. The first observation is that all these concentrations are low by comparison with those observed in adults on methadone maintenance therapy. However, the more surprising observation is the relative homogenous concentrations along the hair locks in each specific case. This raises concerns around the possibility that contamination could have occurred prior to sampling and makes it hard to reach a conclusion regarding the possibility of repeated methadone exposure in the months prior the incidents. In these cases it was impossible to conclude that the children were deliberately administered methadone. The results of the analysis of hair could indicate that they were in an environment where methadone was being used and where the drug was not being handled and stored with appropriate care. The homogenous concentrations found on segmental analyses could be indicative of external contamination that may have arisen not only from direct contamination with the drug but also via contamination with body fluids at the post mortem or from sweat produced close to the time of the incident. In view of these results we concluded that a single determination should not be used firmly to discriminate long-term exposure to a drug.
美沙酮虽未获准用于儿童,但可用于治疗新生儿阿片类戒断综合征。在过去的 2 年中,我们实验室被要求检测来自昏迷住院儿童的头发中的美沙酮和其主要代谢物 EDDP,这些儿童的体液中已经检测到美沙酮(4 例),或者这些儿童已经死亡且已经证实美沙酮用药过量(2 例)。在所有这些情况下,分段分析显示沿发束的药物含量大致相同。因此,我们认为污染是一个问题,对结果的解释是一个值得特别关注的挑战。在用二氯甲烷进行去污和分段后,将头发切成小块,在 40°C 下孵育过夜,进行液-液提取,并使用 LC-MS/MS 进行分析,每个化合物使用 2 个转换。美沙酮和 EDDP 的定量下限均为 10 pg/mg。在涉及住院儿童的第一个系列中,得到了以下结果:*病例 1:4 x 1 cm 节段,美沙酮含量为 0.05-0.08 ng/mg,未检测到 EDDP,*病例 2:4 x 1 cm 节段,美沙酮含量为 0.13-0.15 ng/mg,EDDP 含量为 0.02 ng/mg,*病例 3:3 x 1.5 cm 节段,美沙酮含量为 0.07-0.09 ng/mg,EDDP 含量为 0.01-0.03 ng/mg,*病例 4:6 x 2 cm 节段,美沙酮含量为 0.06-0.13 ng/mg,EDDP 含量为 0.02-0.03 ng/mg。从美沙酮过量死亡的儿童中获得了以下浓度:*病例 5:2 x 2 cm 节段,美沙酮含量为 0.53-0.58 ng/mg,未检测到 EDDP,*病例 6:4 x 1 cm 节段,美沙酮含量为 0.44-0.77 ng/mg,EDDP 含量为 0.04-0.06 ng/mg。第一个观察结果是,与接受美沙酮维持治疗的成年人相比,所有这些浓度都较低。然而,更令人惊讶的观察结果是,在每个特定病例中,发束中的浓度相对均匀。这引发了人们对污染可能在采样前发生的可能性的担忧,并且难以就事件发生前几个月内重复接触美沙酮的可能性得出结论。在这些情况下,无法确定儿童是故意服用美沙酮。头发分析结果表明,他们处于使用美沙酮的环境中,而且药物没有得到适当的处理和储存。分段分析中发现的均匀浓度可能表明存在外部污染,这种污染不仅可能直接来自药物污染,还可能来自死后的体液污染,或者来自事发时附近产生的汗液。鉴于这些结果,我们得出结论,单次测定不应用于坚定地区分长期接触药物。